FindTrial
Sign In

Study of hydroxocobalamin at a new concentration for cobalamin-related remethylation disorders.

Status
Not yet recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516862-12-00
Enrollment
6
Registered
2025-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydroxycobalamin deficiency

Brief summary

measurement of tHcy blood concentration at baseline and at 3-, 6-, 9-, 12-, 12-, 15-, 18- and 24-month follow-up and comparison of concentrations in both treatment arms

Interventions

DRUGCOBALAMIN

Sponsors

Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Design outcomes

Primary

MeasureTime frame
measurement of tHcy blood concentration at baseline and at 3-, 6-, 9-, 12-, 12-, 15-, 18- and 24-month follow-up and comparison of concentrations in both treatment arms—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026